420 related articles for article (PubMed ID: 29404790)
1. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes.
Moghadamnia F; Ghoraeian P; Minaeian S; Talebi A; Farsi F; Akbari A
J Gastrointest Cancer; 2020 Mar; 51(1):271-279. PubMed ID: 31102171
[TBL] [Abstract][Full Text] [Related]
3. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
8. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Huang XX; Yang L
Biomed Pharmacother; 2019 Apr; 112():108611. PubMed ID: 30797148
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
11. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer.
Xie H; Ren X; Xin S; Lan X; Lu G; Lin Y; Yang S; Zeng Z; Liao W; Ding YQ; Liang L
Oncotarget; 2016 May; 7(18):26680-91. PubMed ID: 27058418
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of miR-20a and miR-145 in Colorectal Tumors as Potential Location-specific miRNAs.
Eslamizadeh S; Zare AA; Talebi A; Tabaeian SP; Eshkiki ZS; Heydari-Zarnagh H; Akbari A
Microrna; 2021; 10(1):66-73. PubMed ID: 33349227
[TBL] [Abstract][Full Text] [Related]
16. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
[TBL] [Abstract][Full Text] [Related]
17. LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effect.
Zaniani NR; Oroujalian A; Valipour A; Peymani M
Mol Biol Rep; 2021 Aug; 48(8):6093-6101. PubMed ID: 34374893
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
[TBL] [Abstract][Full Text] [Related]
19. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
Sun P; Sun D; Wang X; Liu T; Ma Z; Duan L
Cancer Biomark; 2015; 15(4):391-6. PubMed ID: 26406866
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
